Quick Summary Mesenchymal stem cell (MSC) therapy for IBD (Crohn’s disease and ulcerative colitis) reduces inflammation, supports repair of damaged intestinal tissue, and helps balance immune response. It is not a replacement for biologics or steroids but may work alongside them. Clinical trials show improved gut symptoms and mucosal healing
Quick Summary Stem cell therapy for autism aims to reduce brain inflammation, modulate the immune system, and support nerve cell communication. Types of stem cells studied include umbilical cord derived cells, bone marrow stem cells, and umbilical cord blood cells. Early clinical trials show potential improvements in social interaction and
Quick Summary In 2026, stem cell therapy for diabetes shows measurable improvement in 60-80% of patients, including better blood sugar control, reduced insulin use, and improved insulin resistance. Type 2 diabetes patients often respond better than type 1. However, full remission remains uncommon, and results depend on disease duration, treatment
